| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.0B | $0.1B | $0.1B | $-0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $4.04 | $0.50 | $3.56 | $3.49 | $-4.97 | $1.64 | $2.33 | $1.66 |
| EPS (Diluted) | $4.00 | $0.50 | $3.51 | $3.43 | $-4.97 | $1.61 | $2.28 | $1.62 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.3B | $5.0B | $5.0B | $5.1B | $4.0B | $3.9B | $4.1B | $3.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | $0.1B |
| Total Liabilities | $4.7B | $4.6B | $4.6B | $4.6B | $3.6B | $3.5B | $3.6B | $2.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.6B | $0.5B | $0.4B | $0.5B | $0.4B | $0.5B | $0.5B | $0.4B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | — |
| Investing Cash Flow | $0.1B | $0.2B | $-0.2B | $-0.3B | $0.1B | $0.1B | $-0.2B | — |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.2B | $-0.0B | $-0.0B | $0.2B | $0.1B | $-0.2B | $0.3B | — |